Nasal Drug Delivery Market to Witness Healthy Growth in Coming Years

Increasing prevalence of various respiratory disorders and demand for non-invasive techniques to drive global nasal drug delivery market

According to TechSci Research report, “Global Nasal Drug Delivery Market By Drug Type (Anesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, Others), By Dosage Form (Drops, Sprays, Powder, Gels & Ointments), By Container Type (Non-pressurized Containers, Pressurized Containers), By Basis of System (Unit Dose, Multi-Dose, Metered Dose), By Delivery Technologies (Spray, Nebulizers, Inhalers, Others), By Therapeutic Applications (Rhinitis, Asthma, Nasal Congestion, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Others), By End User (Home Care Settings, Hospitals & Clinics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), By Region, Forecast & Opportunities, 2025”, the market is predicted to grow at a significant CAGR during the forecast period. The global nasal drug delivery market is primarily driven by increasing prevalence of various respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disease (COPD) and pneumonia around the globe coupled with growing patient preference for nasal products. The efficacy and easy administration properties of nasal drug delivery devices is creating their high demand in global market. Moreover, development of new and advanced nasal drug delivery devices and increasing awareness among patients about the benefits of these products is expected to propel the market growth through 2025. Also, the growing demand for non-invasive techniques and less painful treatments are creating profitable opportunity for nasal drug delivery device manufacturers.

Additionally, nasal drug delivery devices provide self-medication, which does not require visit to the doctor and makes it easy for the patients to stay and medicate at home. Thus, with increasing demand for home healthcare devices and growing adoption of self-administration practices, global nasal drug delivery market is expected to witness substantial growth during the forecast period. 

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “Global Nasal Drug Delivery Market”

https://www.techsciresearch.com/report/nasal-drug-delivery-market/5174.html

The global nasal drug delivery market is segmented based on drug type, dosage form, container type, basis of system, delivery technologies, therapeutic applications, end user, distribution channel and region. Based on dosage form, the market can be segmented into drops, sprays, powder, gels & ointments. Among them, sprays segment contributed to highest revenue growth in 2019 owing to growing rising cases of infections and allergic rhinitis, leading to high demand for generic forms of spray drugs. However, the drops segment is anticipated to undergo fastest CAGR during the forecast period as they are affordable, and their treatment success rates is high compared to other dosage forms.

Major players operating in the global nasal drug delivery market include GlaxoSmithKline Plc., Pfizer, Inc., AstraZeneca PLC, Novartis AG, Becton Dickson & Company, Promius Pharma LLC, 3M COMPANY, Johnson & Johnson Services, Inc., Sanofi S.A., Merck & Co., Inc., Cadila Pharmaceuticals , Aegis Therapeutics, LLC, B.F. Ascher & Company, Inc., ENT Technologies Pty. Ltd. and AptarGroup, Inc. Leading companies are focusing on new product development, and are undergoing joint ventures to increase their share in global nasal drug delivery market.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5174

Customers can also request for 10% free customization on this report.

“The presence of major manufacturers and increasing cases of respiratory disorders in countries like United States and Canada are making North America a lucrative market for nasal drug delivery. The region is further expected to dominate through 2025 owing to advancements in healthcare and launch of new technology equipped nasal drug delivery devices. However, Asia Pacific is anticipated to witness fastest CAGR during the forecast period due to increasing patient pool suffering from chronic and respiratory disorders and increasing per capita disposable income,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Nasal Drug Delivery Market By Drug Type (Anesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, Others), By Dosage Form (Drops, Sprays, Powder, Gels & Ointments), By Container Type (Non-pressurized Containers, Pressurized Containers), By Basis of System (Unit Dose, Multi-Dose, Metered Dose), By Delivery Technologies (Spray, Nebulizers, Inhalers, Others), By Therapeutic Applications (Rhinitis, Asthma, Nasal Congestion, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Others), By End User (Home Care Settings, Hospitals & Clinics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global nasal drug delivery market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global nasal drug delivery market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]